Recent studies on colorectal cancers have suggested that TESC modulates tumorigenic activity through AKT-dependent nuclear factor κB (NF-κB) activation pathway and serves as a potential oncotarget18,19. The gene discussed is AKT1; the disease is colorectal cancer.